Michael Hallek to Cell Line, Tumor
This is a "connection" page, showing publications Michael Hallek has written about Cell Line, Tumor.
Connection Strength
0.140
-
Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene. 2018 10; 37(42):5682-5693.
Score: 0.024
-
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018 08 01; 78(15):4270-4281.
Score: 0.024
-
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. Biomed Res Int. 2018; 2018:1023490.
Score: 0.024
-
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018 02 15; 9(1):697.
Score: 0.023
-
Lamin B1 regulates somatic mutations and progression of B-cell malignancies. Leukemia. 2018 02; 32(2):364-375.
Score: 0.023
-
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. Br J Cancer. 2017 Feb 28; 116(5):600-608.
Score: 0.022